Breast Cancer Pharmacology (medical)

Minimal important differences of EORTC QLQ-C30 and QLQ-BR23 for metastatic breast cancer patients in a Japanese population: results from the RESQ trial

Yosuke Aoyama, Kosuke Kashiwabara, Yuichiro Kikawa, Naruto Taira, Hirofumi Mukai, Masato Takahashi
Springer Nature · 2026-03-30 · DOI 10.1007/s12282-026-01852-5

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →